SEC Form D · Amendment · filed January 7, 2022
Triumvira Immunologics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (33)
Brian M. Bloom · AUSTIN, TXDirectorShaan C. Gandhi, Md, Dphil · AUSTIN, TXDirectorLee M. Cooper · AUSTIN, TXDirectorTeresa C. Mcroberts · AUSTIN, TXExecCynthia M. Collins, Mba · AUSTIN, TXDirectorDaniel C. Janse · AUSTIN, TXDirectorPaul Lammers, Md, Msc · AUSTIN, TXExec · DirectorJurgen M. Eckhardt · AUSTIN, TXDirectorJon C. Irvin · AUSTIN, TXExecElizabeth C. Williams · AUSTIN, TXDirectorScott M. Smith · AUSTIN, TXDirectorDavid A. Newberg · JANESVILLE, WIExec · DirectorEric G. Schutt · JANESVILLE, WIDirectorGregory D. Smith · JANESVILLE, WIDirectorAndrew Cunningham · Washington, Washington, D.C.ExecJeremy Burger · Seattle, WADirectorGregory R. Piefer · JANESVILLE, WIDirectorRobert F. Bierig · Chicago, ILExecAdam Castelbaum · PHILADELPHIA, PADirectorJacob Bond · Vancouver, WADirectorNatalie Levy · Boulder, CODirectorDennis Tilley · Seattle, WADirectorVernon D. Gair Jr · Chicago, ILDirectorAndrea K. Jackson · Madison, WIDirectorSteven K. Galson · Madison, WIExec · DirectorManeesh K. Arora · Madison, WIDirectorTerrence K. Brady · Madison, WIDirectorPaul K. Berns · Madison, WIDirectorBrandon Arvanaghi · Miami Beach, FLDirectorDanting Wang · Grand Cayman, Cayman IslandsExecYiran Liu · Grand Cayman, Cayman IslandsExecDanting Wang · Grand Cayman, Cayman IslandsDirectorKennedy Lewis Investments Holdings II LLC · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗